Zusammenfassung
Mit der Publikation der Nationalen VersorgungsLeitlinie „Nierenerkrankungen bei Diabetes im Erwachsenenalter“ 2010 wurde ein Meilenstein im Versorgungsmanagement dieser Patientengruppe erreicht. Die Beurteilung der qualitativen Umsetzung dieser Leitlinie und ihrer Auswirkung auf wesentliche Ergebnisparameter steht gegenwärtig aus. Mit der neuen Leitlinie der Kidney Disease: Improving Global Outcomes (KDIGO, 2012) zur Evaluation und zum Management der chronischen Nierenkrankheit sowie ergänzenden internationalen Leitlinien werden wesentliche Aspekte der Klassifikation, Prognoseabschätzung, Behandlungsziele und interdisziplinären Kooperation angesprochen, die für die Betreuung von Diabetespatienten mit Nierenerkrankungen von grundsätzlicher Bedeutung sind. Dieser Beitrag fasst einige dieser Aspekte zusammen mit dem Ziel, sie in das aktuelle Versorgungsmanagement zu integrieren.
Abstract
With the publication in 2010 of the German guidelines on renal diseases in adult diabetes mellitus, a milestone in the care of this patient group was achieved. The evaluation of quality and clinical results of these guidelines in daily practice is currently pending. The international guidelines on the evaluation and management of chronic kidney disease as developed by the “kidney disease: improving global outcomes (KDIGO)” initiative in 2012 and supplementary international guidelines significantly influenced the care for these patients with the focus on prognosis, risk stratification, therapeutic goals and interdisciplinary cooperation. The aim of this article is the implementation some important aspects of these guidelines into the current treatment and management of patients with diabetes mellitus and renal disease.
Literatur
Nationale VersorgungsLeitlinie Nierenerkrankungen im Erwachsenenalter. http://www.awmf.org/uploads/tx_szleitlinien/nvl-001dl_S3_Nierenerkrankungen_bei_Diabetes_Erwachsene_2013-05_01.pdf. Zugegriffen: 19. Sept. 2014
European Society of Hypertension, European Society of Cardiology (ESH/ESC) (2013) Guidelines for the management of arterial hypertension. http://www.esh2013.org/wordpress/wp-content/uploads/2013/06/ESC-ESH-Guidelines-2013.pdf. Zugegriffen: 13. Mai 2014
Kidney Disease: Improving Global Outcomes (2012) Clinical practice guideline for the evaluation and management of chronic kidney disease (2013) Kidney Int Suppl 3(1). http://www.kidney.org/professionals/KDOQI/guidelines_diabetesUp/diabetes-ckd-update-2012.pdf. Zugegriffen: 13. Mai 2014
Kidney Disease Outcomes Quality Initiative (2012) Clinical practice guideline for diabetes and CKD: update 2012. http://www.kidney.org/professionals/KDOQI/guidelines_diabetesUp/diabetes-ckd-update-2012.pdf. Zugegriffen: 13. Mai 2014
Kidney Disease: Improving Global Outcomes (2013) Clinical practice guideline for lipid management in chronic kidney disease. http://www.kdigo.org/clinical_practice_guidelines/Lipids/KDIGO%20Lipid%20Management%20Guideline%202013.pdf. Zugegriffen: 22. Juli 2014
Pommer W (2009) Nephropathie bei Diabetes mellitus. Diabetologe 5:563–575
Ramirez SP, McCullough KP, Thumma JR et al (2012) Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: findings from the Diabetes Outcomes and Practice Patterns Study (DOPPS). Diabetes Care 35:2527–2532
Vijan S, Sussman JB, Yudkin JS, Hayward RA (2014) Effect of patients‘ risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. JAMA Intern Med 174(8):1227–1234 DOI 10.10002/jamainternmed.2014.2894
Boer IH de; DCCT/EDIC Research Group (2014) Kidney disease and related findings in the diabetes control and complication trial/epidemiology of diabetes interventions and complications study. Diabetes Care 37:24–30
Charlson ME, Pompei P, Ales KL et al (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Inzucchi SE, Bergenstal RM, Buse JB et al (2012) Management of hyperglycemia in type 2 diabetes: a patient centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologica 55:1577–1596
Inzucchi SE, Bergenstal RM, Buse JB et al (2012) Management of hyperglycemia in type 2 diabetes: a patient centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35:1364–1379
Zeyfang A, Bahrmann A, Wernecke J (2010) Diabetes mellitus im Alter. DDG Praxisleitlinie. Diabetologie 5(Suppl 2):166–171
Abaterusso C, Lupo A, Ortalda V et al (2008) Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease. Clin J Am Soc Nephrol 3:1185–1194
Stahn A, Pistroch F, Ganz X et al (2014) Relationship between hypoglycemic episodes and ventricular arrhythmias in patients with type 2 diabetes and cardiovascular disease: silent hypoglycemias and silent arrhythmias. Diabetes Care 37:516–525
Moen MF, Zhan M, Hsu VD et al (2009) Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 4:1121–1127
Dunkler D, Dehghan M, Teo KK et al (2013) Diet and kidney disease in high-risk individuals with type 2 diabetes. JAMA Int Med 14:1682–1692
Hasslacher C (2013) Antidiabetische Therapie bei Niereninsuffizienz. Diabetologe 9:613–621
Kovesdy CP, Park JC, Kalantar-Zadeh K (2010) Glycemic control and burnt out diabetes in ESRD. Semin Dial 23:146–156
Takahashi A, Kubote T, Shibahara N et al (2004) The mechanism of hypoglycemia caused by hemodialysis. Clin Nephrol 62:362–368
Navaneethan SD, Nigwekar SU, Sehgal AR, Stripolli GF (2009) Aldosterone antagonists for preventing the progression: a systematic review and meta-analysis. Clin J Am Soc Nephrol 4:542–551
Al-Hamid A, Ghaleb M, Aljadhey H, Aslanpour Z (2013) A systematic review of hospitalisation resulting from medicine related problems in adult patients. Br J Clin Pharmacol 28. DOI 10.1111/bcp.12293
Hemmelgarn BR, Zhang J, Manns BJ et al (2006) Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 69:2155–2161
PatientenLeitlinie zur Nationalen VersorgungsleitLinie Nierenerkrankungen bei Diabetes im Erwachsenenalter. http://www.versorgungsleitlinien.de/patienten/pdf/nvl-t2dm-nephropathie-patienten-1.0.pdf. Zugegriffen: 13. Mai 2014
Einhaltung ethischer Richtlinien
Interessenkonflikt. W. Pommer und B. Oser geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pommer, W., Oser, B. Diabetespatienten mit chronischer Niereninsuffizienz. Diabetologe 10, 589–602 (2014). https://doi.org/10.1007/s11428-014-1274-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-014-1274-9